Status:
COMPLETED
Use of In-Line Filtration in Critically Ill Children
Lead Sponsor:
Hannover Medical School
Collaborating Sponsors:
Pall Corporation
B. Braun Melsungen AG
Conditions:
Critical Illness
Eligibility:
All Genders
Up to 18 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether the use of in-line filtration shows any effect on the outcome of sepsis, systemic inflammatory response syndrome (SIRS), thrombosis, or organ failure ...
Detailed Description
Scientific background: Particulate contamination of infusion solutions and their systemic administration during infusion therapy has been linked to various clinical problems. Organ failure and Multi...
Eligibility Criteria
Inclusion
- Children admitted to pediatric intensive care unit (PICU)
Exclusion
- Suspected death within 48 hours
- Duration of PICU stay less than 6 hours
- Patients recruited for Simulect or Sintra Study
Key Trial Info
Start Date :
February 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
821 Patients enrolled
Trial Details
Trial ID
NCT00209768
Start Date
February 1 2005
End Date
September 1 2008
Last Update
December 1 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hannover Medical School
Hanover, Lower Saxony, Germany, 30625